Generics
Sputnik V Meets Primary Endpoint of Safety in India Phase 2 Clinical Trial
11 January 2021 - - An independent Data and Safety Monitoring Board has reviewed the safety data from the phase 2 clinical trial of the Sputnik V vaccine and recommended the phase 3 recruitment and co...
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA
8 January 2021 - - US-based Amneal Pharmaceuticals, Inc. (NYSE: AMRX) has received approval of an additional strength of 500 mg to its Abbreviated New Drug Application, from the US Food and Drug Admin...
Early Multidrug COVID-19 Treatment Can Prevent Hospitalizations and Deaths, According to Physicians for Civil Defense
4 January 2021 - - An international collaboration of physicians has just published an updated protocol for early at-home treatment of COVID-19, which recognizes the three stages of the disea...
EpiVax reveals peptide therapeutic immunogenicity assessment programme progress
30 December 2020 - EpiVax Inc, a US-based biotechnology company, has revealed an update on the progress of its peptide therapeutic immunogenicity assessment programme, it was reported on Tuesday.The p...
The FDA approves first generic glucagon to treat severe hypoglycemia to improve competition and access to more affordable medicines
29 December 2020 - Public health agency the US Food and Drug Administration announced on Monday that it authorised the first generic of glucagon for injection USP in 1 mg/vial in an emergency kit for ...
Peak Pharma Commercial Partners establishes Resilia Pharmaceuticals and starts operations
29 December 2020 - Peak Pharma Commercial Partners, a United States-based investment fund that deals with the acquisition and growth of branded, generic and over-the-counter pharmaceutical products, h...